17 August 2025 : Clinical Research
Evaluation of Inflammatory Biomarkers in Parotid Tumors
Aykut Ikinciogullari
ABCDEF 1*, Burak Hazir ABCDEF 1, Erdem Aggunlu ABCDEF 1, Mustafa Colak ACDEF 1, Serdar Ensari ADEF 1, Haci Huseyin Dere ADEF 1
DOI: 10.12659/MSM.947334
Med Sci Monit 2025; 31:e947334
Table 2 Age distribution and sex ratio in benign and malignant tumor groups.
| Benign tumors | Malignant tumors | All tumors | |||||
|---|---|---|---|---|---|---|---|
| Pleo. Ad. (n=97) | Warthin (n=62) | Other benign (n=18 | Low Gr. (n=13) | High Gr. (n=12) | Other (n=4) | ||
| Age | |||||||
| Mean (yrs) | 41.98 | 57.89 | 49.39 | 42.54 | 61.17 | 51.5 | 48.75 |
| SD | 14.88 | 8.73 | 13.01 | 19.98 | 13.54 | 17.79 | 15.39 |
| Range (yrs) | 13–71 | 36–74 | 21–73 | 12–76 | 48–90 | 34–76 | 12–90 |
| Sex | |||||||
| Female, n (%) | 49 (50.52) | 15 (24.19) | 10 (55.56) | 10 (76.92) | 5 (41.67) | 2 (50) | 91 (44.17) |
| Male, n (%) | 48 (49.48) | 47 (75.81) | 8 (44.44) | 3 (23.08) | 7 (58.33) | 2 (50) | 115 (55.83) |